129 related articles for article (PubMed ID: 31627772)
1. Multidrug-resistant tuberculosis in Lisbon: unfavourable treatment and associated factors, 2000-2014.
Bhering M; Kritski A; Nunes C; Duarte R
Int J Tuberc Lung Dis; 2019 Oct; 23(10):1075-1081. PubMed ID: 31627772
[No Abstract] [Full Text] [Related]
2. Predictive factors for unfavourable treatment in MDR-TB and XDR-TB patients in Rio de Janeiro State, Brazil, 2000-2016.
Bhering M; Duarte R; Kritski A
PLoS One; 2019; 14(11):e0218299. PubMed ID: 31747405
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for unfavourable treatment outcomes among rifampicin-resistant tuberculosis patients in Tajikistan.
Makhmudova M; Maxsumova Z; Rajabzoda A; Makhmadov A; van den Hof S; Mirtskhulava V
Int J Tuberc Lung Dis; 2019 Mar; 23(3):331-336. PubMed ID: 30871664
[TBL] [Abstract][Full Text] [Related]
4. First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017.
Glasauer S; Altmann D; Hauer B; Brodhun B; Haas W; Perumal N
PLoS One; 2019; 14(6):e0217597. PubMed ID: 31188848
[TBL] [Abstract][Full Text] [Related]
5. Multidrug-resistant tuberculosis in Alberta and British Columbia, 1989 to 1998.
Hersi A; Elwood K; Cowie R; Kunimoto D; Long R
Can Respir J; 1999; 6(2):155-60. PubMed ID: 10322098
[TBL] [Abstract][Full Text] [Related]
6. Mortality of tuberculosis patients during treatment in Israel, 2000-2010.
Shuldiner J; Leventhal A; Chemtob D; Mor Z
Int J Tuberc Lung Dis; 2014 Jul; 18(7):818-23. PubMed ID: 24902558
[TBL] [Abstract][Full Text] [Related]
7. Treatment outcome of multidrug-resistant tuberculosis in Japan - the first cross-sectional study of Japan tuberculosis surveillance data.
Kawatsu L; Uchimura K; Izumi K; Ohkado A; Yoshiyama T
BMC Infect Dis; 2018 Aug; 18(1):445. PubMed ID: 30170549
[TBL] [Abstract][Full Text] [Related]
8. Increase in multidrug-resistant tuberculosis (MDR-TB) in Alberta among foreign-born persons: implications for tuberculosis management.
Long R; Langlois-Klassen D
Can J Public Health; 2013 Jan; 104(1):e22-7. PubMed ID: 23618116
[TBL] [Abstract][Full Text] [Related]
9. Multidrug-resistant tuberculosis in Norway: a nationwide study, 1995-2014.
Jensenius M; Winje BA; Blomberg B; Mengshoel AT; Lippe Bv; Hannula R; Bruun JN; Knudsen PK; Rønning JO; Heldal E; Dyrhol-Riise AM
Int J Tuberc Lung Dis; 2016 Jun; 20(6):786-92. PubMed ID: 27155182
[TBL] [Abstract][Full Text] [Related]
10. Treatment outcomes of multi drug resistant and rifampicin resistant Tuberculosis in Zimbabwe: A cohort analysis of patients initiated on treatment during 2010 to 2015.
Matambo R; Takarinda KC; Thekkur P; Sandy C; Mharakurwa S; Makoni T; Ncube R; Charambira K; Zishiri C; Ngwenya M; Nyathi S; Chiteka A; Chikaka E; Mutero-Munyati S
PLoS One; 2020; 15(4):e0230848. PubMed ID: 32353043
[TBL] [Abstract][Full Text] [Related]
11. Multidrug-resistant tuberculosis in the Northern Territory: A 10-year retrospective case series.
Judge D; Krause V
Commun Dis Intell Q Rep; 2016 Sep; 40(3):E334-E339. PubMed ID: 28278406
[TBL] [Abstract][Full Text] [Related]
12. Incidence and factors associated with unfavourable treatment outcome among patients with rifampicin-resistant pulmonary tuberculosis in Yaoundé, Cameroon.
Kuaban A; Balkissou AD; Ekongolo MCE; Nsounfon AW; Pefura-Yone EW; Kuaban C
Pan Afr Med J; 2021; 38():229. PubMed ID: 34046134
[TBL] [Abstract][Full Text] [Related]
13. Multidrug-resistant tuberculosis in Australia, 1998-2012.
Francis JR; Manchikanti P; Blyth CC; Denholm J; Lowbridge C; Coulter C; Donnan E; Stapledon R; Krause VL; Waring J
Int J Tuberc Lung Dis; 2018 Mar; 22(3):294-299. PubMed ID: 29471907
[TBL] [Abstract][Full Text] [Related]
14. Notified Incidence of Tuberculosis in Foreign-born Individuals in Jeju Province, Republic of Korea.
Kim DS; Bae JM
J Prev Med Public Health; 2019 Jan; 52(1):66-70. PubMed ID: 30742763
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and control of tuberculosis in Victoria, a low-burden state in south-eastern Australia, 2005-2010.
Lavender CJ; Globan M; Kelly H; Brown LK; Sievers A; Fyfe JA; Lauer T; Leslie DE
Int J Tuberc Lung Dis; 2013 Jun; 17(6):752-8. PubMed ID: 23676157
[TBL] [Abstract][Full Text] [Related]
16. High treatment success rate among multidrug-resistant tuberculosis patients in Myanmar, 2012-2014: a retrospective cohort study.
Thu MK; Kumar AMV; Soe KT; Saw S; Thein S; Mynit Z; Maung HMW; Aung ST
Trans R Soc Trop Med Hyg; 2017 Sep; 111(9):410-417. PubMed ID: 29351672
[TBL] [Abstract][Full Text] [Related]
17. The imminent threat of multidrug-resistant tuberculosis in Singapore.
Chee CB; Khin-Mar KW; Cutter J; Wang YT
Singapore Med J; 2012 Apr; 53(4):238-40. PubMed ID: 22511044
[TBL] [Abstract][Full Text] [Related]
18. Burden of multidrug-resistant tuberculosis in England: a focus on prevalent cases.
Lalor MK; Perkins S; Thomas HL
Int J Tuberc Lung Dis; 2019 Jun; 23(6):707-713. PubMed ID: 31315703
[TBL] [Abstract][Full Text] [Related]
19. Multidrug-resistant tuberculosis in New South Wales, Australia, 1999-2010: a case series report.
Roberts-Witteveen A; Reinten T; Christensen A; Sintchenko V; Seale P; Lowbridge C
Int J Tuberc Lung Dis; 2015 Jul; 19(7):850-6. PubMed ID: 26056113
[TBL] [Abstract][Full Text] [Related]
20. [Tuberculosis surveillance in Sicily, Italy].
Mammina C; Bonura C; Barchitta M; Quattrocchi A; Palermo M; Agodi A
Epidemiol Prev; 2014; 38(6 Suppl 2):83-7. PubMed ID: 25759350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
